Company Filing History:
Years Active: 2023-2025
Title: Innovations in Anti-Tumor Applications by Inventor Ying Kong
Introduction
Ying Kong is a prominent inventor based in Shanghai, China, known for his significant contributions to the field of pharmacology and cancer treatment. With a total of four patents to his name, he has focused on developing innovative compounds that target specific proteins involved in tumor growth.
Latest Patents
Ying Kong's latest patents include groundbreaking work on ALK protein regulators and their anti-tumor applications. One of his notable inventions is a compound of general formula (I) and a compound of general formula (III), both of which have demonstrated a wide range of pharmacological activities. These compounds are designed to degrade specific proteins and inhibit their activity, making them valuable in the treatment of tumors and cancers. The compounds consist of three main components: a small molecule compound (SMBP) that binds to a protein, a linker (LIN), and a ubiquitin ligand (ULM). This innovative design allows for effective degradation of target proteins, showcasing the potential for new cancer therapies.
Career Highlights
Ying Kong is affiliated with Shanghaitech University, where he conducts research and develops his patented compounds. His work has garnered attention in the scientific community for its potential to revolutionize cancer treatment through targeted protein degradation.
Collaborations
Throughout his career, Ying Kong has collaborated with notable colleagues, including Xiaobao Yang and Biao
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.